Psyence Biomedical Ltd. Common Shares (PBM) — Cash Flow-to-Debt Ratio
Psyence Biomedical Ltd. Common Shares (PBM) has a Cash Flow-to-Debt Ratio of -0.05x as of December 2023, meaning its operating cash flow of $-662.00 could theoretically repay 0% of its total liabilities ($12.10K) in one year. Explore Psyence Biomedical Ltd. Common Shares long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Psyence Biomedical Ltd. Common Shares Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Psyence Biomedical Ltd. Common Shares across 4 annual periods. Also explore Psyence Biomedical Ltd. Common Shares (PBM) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Psyence Biomedical Ltd. Common Shares (2022–2025)
Year-by-year debt coverage analysis for Psyence Biomedical Ltd. Common Shares. For market capitalisation and broader financial context, see how much is Psyence Biomedical Ltd. Common Shares worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.28x | $-3.73 Million | $594.37K | ▼ -2482.0% |
| 2024 | -0.24x | $-2.95 Million | $12.10 Million | ▼ -568.3% |
| 2023 | -0.04x | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $16.38 Million | — |